Basic information Uses Safety Supplier Related

5,7-Dichloroimidazo[4,5-b]pyridine

Basic information Uses Safety Supplier Related

5,7-Dichloroimidazo[4,5-b]pyridine Basic information

Product Name:
5,7-Dichloroimidazo[4,5-b]pyridine
Synonyms:
  • 3H-Imidazo[4,5-b]pyridine, 5,7-dichloro-
  • 5,7-dichloro-1H-imidazo[4,5-b]pyridine
  • Nsc264046
  • 5,7-Dichloroimidazo[4,5-b]pyridine
  • 7-dichloro-1H-iMidazo[4
  • (1)5,7-dichloro-3H-imidazo[4,5-b]pyridine
  • 1H-IMidazo[4,5-b]pyridine, 5,7-dichloro-
  • 5,7-dichloro-7aH-imidazo[4,5-b]pyridine
CAS:
24485-01-6
MF:
C6H3Cl2N3
MW:
188.01
Product Categories:
  • CHIRAL CHEMICALS
  • Heterocycle-Pyridine series
Mol File:
24485-01-6.mol
More
Less

5,7-Dichloroimidazo[4,5-b]pyridine Chemical Properties

Melting point:
273-274 °C
Boiling point:
200.8±50.0 °C(Predicted)
Density 
1.79±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
5.37±0.40(Predicted)
Appearance
Off-white to pink Solid
InChI
InChI=1S/C6H3Cl2N3/c7-3-1-4(8)11-6-5(3)9-2-10-6/h1-2H,(H,9,10,11)
InChIKey
IKJFWUNKUZVHGU-UHFFFAOYSA-N
SMILES
C12NC=NC1=C(Cl)C=C(Cl)N=2
More
Less

Safety Information

HS Code 
2933998090
More
Less

5,7-Dichloroimidazo[4,5-b]pyridine Usage And Synthesis

Uses

5,7-Dichloro-1H-imidazo[4,5-B]pyridine is an important type of imidazopyridine compound with good antimicrobial and bactericidal effects.

Synthesis

14432-11-2

24485-01-6

General procedure for the synthesis of 5,7-dichloro-1H-imidazo[4,5-B]pyridine from 7-nitro-3H-imidazo[4,5-B]pyridine 4-oxide: 7-nitro-1H-imidazo[4,5-b]pyridine 4-oxide (2.0 g, 11.04 mmol) was added batchwise to a mixed solution of ice-bath-cooled (0 °C) phosphoryl chloride (POCl3, 30 mL , 322 mmol) and N,N-dimethylformamide (DMF, 15 mL) in a mixed solution. Subsequently, the reaction mixture was heated to 120°C and maintained for 3 hours. After completion of the reaction, it was cooled to room temperature, slowly poured into ice water and neutralized with 5 M sodium hydroxide solution. The reaction mixture was extracted with ethyl acetate (3 × 75 mL). The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to afford the crude product 5,7-dichloro-3H-imidazo[4,5-b]pyridine (1.86 g, 9.89 mmol, 90% yield), which was used directly in the next reaction without further purification. Mass spectrum (electrospray ionization) m/e 188 ([M+H]+). 1H NMR (400 MHz, methanol-d4) δ 8.45 (broad single peak, 1H), 7.46 (single peak, 1H).

References

[1] Patent: WO2013/95761, 2013, A1. Location in patent: Page/Page column 32; 33; 34
[2] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 8, p. 1757 - 1760
[3] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 8, p. 1757 - 1760

5,7-Dichloroimidazo[4,5-b]pyridineSupplier

Chiba Pharmaceutical Science and technology Co, Ltd. Gold
Tel
0531-81313138 13066006660
Email
chibapharm@foxmail.com
Shanghai Taijilin Industrial Co., Ltd. Gold
Tel
021-50630626 18964684208
Email
kate@tajilin.com
Tongchuang Pharma(Suzhou). Co., Ltd. Gold
Tel
0512-63263366 18912765016
Email
tongtf110@sina.com
Suzhou bonei Biotechnology Co., Ltd Gold
Tel
13812661976
Email
info@szbiolight.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
More
Less

5,7-Dichloroimidazo[4,5-b]pyridine(24485-01-6)Related Product Information